Abionyx Pharma affiche 4,1 millions deuros de trsorerie fin 2023 - Option Finance

ABNX Stock  EUR 1.21  0.03  2.42%   
About 61% of Abionyx Pharma's investor base is looking to short. The analysis of current outlook of investing in Abionyx Pharma SA suggests that many traders are alarmed regarding Abionyx Pharma's prospects. The current market sentiment, together with Abionyx Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Abionyx Pharma SA stock news signals to limit their universe of possible portfolio assets.
  
Abionyx Pharma affiche 4,1 millions deuros de trsorerie fin 2023 Option Finance

Read at news.google.com
Google News at Macroaxis
  

Abionyx Pharma Fundamental Analysis

We analyze Abionyx Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abionyx Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abionyx Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Abionyx Pharma is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Abionyx Pharma SA Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Abionyx Pharma stock to make a market-neutral strategy. Peer analysis of Abionyx Pharma could also be used in its relative valuation, which is a method of valuing Abionyx Pharma by comparing valuation metrics with similar companies.

Complementary Tools for Abionyx Stock analysis

When running Abionyx Pharma's price analysis, check to measure Abionyx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abionyx Pharma is operating at the current time. Most of Abionyx Pharma's value examination focuses on studying past and present price action to predict the probability of Abionyx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abionyx Pharma's price. Additionally, you may evaluate how the addition of Abionyx Pharma to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges